Wild type and melanoma-associated mutant p16INK4a proteins do not oligomerize in vivo

Pigment Cell and Melanoma Research

Volumn 22, Issue 1, 2009, Pages 131-133

  McKenzie, Heather ^a   Becker, Therese M ^a   Scurr, Lyndee L ^a   Kefford, Richard F ^a   Rizos, Helen ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

CDK4; Melanoma; Oligomerize; P16INK4a

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 2A; EPITOPE; HEMAGGLUTININ; RETINOBLASTOMA PROTEIN;

GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LETTER; MELANOMA; MELANOMA CELL; MUTANT; NONHUMAN; OLIGOMERIZATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN VARIANT; TUMOR SUPPRESSOR GENE; WILD TYPE;

BONE NEOPLASMS; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DIMERIZATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENES, DOMINANT; HUMANS; IMMUNOPRECIPITATION; MELANOMA; MUTATION; OSTEOSARCOMA; SUBCELLULAR FRACTIONS; TUMOR CELLS, CULTURED;

EID: 58449129358     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2008.00530.x     Document Type: Letter

References (14)

1. INK4a mutants in melanoma cells despite retention of cyclin-dependent kinase 4 binding. Clin. Cancer Res. 7, 3282 3288.
2. Cammett, T. J., Luo, L. Peng, Z. Y. (2003). Design and characterization of a hyperstable p16INK4a that restores Cdk4 binding activity when combined with oncogenic mutations. J. Mol. Biol. 327, 285 297.
3. Ghiorzo, P., Villaggio, B., Sementa, A. R. et al. (2004). Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patients. Hum. Pathol. 35, 25 33.
4. Goldstein, A. M., Chan, M., Harland, M. et al. (2006). High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res. 66, 9818 9828.
5. Parry, D. Peters, G. (1996). Temperature-sensitive mutants of p16CDKN2 associated with familial melanoma. Mol. Cell. Biol. 16, 3844 3852.
6. ARF. Proc. Natl Acad. Sci. USA 94, 669 673.
7. Rizos, H., Darmanian, A. P., Holland, E. A., Mann, G. J. Kefford, R. F. (2001). Mutations in the INK4a/ARF melanoma susceptibility locus functionally impair p14ARF. J. Biol. Chem. 276, 41424 41434.
8. E4F transcriptional repressor enhances cell cycle inhibition. J. Biol. Chem. 278, 4981 4989.
9. Ruas, M., Gregory, F., Jones, R., Poolman, R., Starborg, M., Rowe, J., Brookes, S. Peters, G. (2007). CDK4 and CDK6 delay senescence by kinase-dependent and p16INK4a-independent mechanisms. Mol. Cell. Biol. 27, 4273 4282.
10. Serrano, M., Hannon, G. J. Beach, D. (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704 707.
11. INK4A: structural characterization of wild-type and mutant proteins by NMR and circular dichroism. Biochemistry 35, 9475 9487.
12. Walker, G. J., Gabrielli, B. G., Castellano, M. Hayward, N. K. (1999). Functional reassessment of P16 variants using a transfection-based assay. Int. J. Cancer 82, 305 312.
13. Yuan, C., Li, J., Selby, T. L., Byeon, I. J. Tsai, M. D. (1999). Tumor suppressor INK4: comparisons of conformational properties between p16(INK4A) and p18(INK4C). J. Mol. Biol. 294, 201 211.
14. Zhang, B. Peng, Z. Y. (1996). Defective folding of mutant p16(INK4) proteins encoded by tumor-derived alleles - communication. J. Biol. Chem. 271, 28734 28737.